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BACKGROUND: Relative risk estimates for long-term ozone (O3) exposure and respiratory mortality from the American Cancer Society Cancer
Prevention Study II (ACS CPS-II) cohort have been used to estimate global O3-attributable mortality in adults. Updated relative risk estimates are
now available for the same cohort based on an expanded study population with longer follow-up.
OBJECTIVES:We estimated the global burden and spatial distribution of respiratory mortality attributable to long-term O3 exposure in adults ≥30 y of
age using updated eﬀect estimates from the ACS CPS-II cohort.
METHODS: We used GEOS-Chem simulations (2 × 2:5 grid resolution) to estimate annual O3 exposures, and estimated total respiratory deaths in
2010 that were attributable to long-term annual O3 exposure based on the updated relative risk estimates and minimum risk thresholds set at the mini-
mum or ﬁfth percentile of O3 exposure in the most recent CPS-II analysis. These estimates were compared with attributable mortality based on the
earlier CPS-II analysis, using 6-mo average exposures and risk thresholds corresponding to the minimum or ﬁfth percentile of O3 exposure in the ear-
lier study population.
RESULTS:We estimated 1.04–1.23 million respiratory deaths in adults attributable to O3 exposures using the updated relative risk estimate and expo-
sure parameters, compared with 0.40–0.55 million respiratory deaths attributable to O3 exposures based on the earlier CPS-II risk estimate and param-
eters. Increases in estimated attributable mortality were larger in northern India, southeast China, and Pakistan than in Europe, eastern United States,
and northeast China.
CONCLUSIONS: These ﬁndings suggest that the potential magnitude of health beneﬁts of air quality policies targeting O3, health co-beneﬁts of climate
mitigation policies, and health implications of climate change-driven changes in O3 concentrations, are larger than previously thought. https://doi.org/
10.1289/EHP1390
Introduction
Ground-level ozone (O3) is formed photochemically in the
atmosphere from nitrogen oxides, non-methane volatile organic
compounds, methane, and carbon monoxide. Ozone exposure has
been associated with a range of health impacts, including mortal-
ity (REVIHAAP 2013; U.S. EPA 2013). Relative risk estimates
based on prospective data from the American Cancer Society
Cancer Prevention Study II (ACS CPS-II) have been applied in
previous analyses of the global burden of mortality attributable to
long-term air pollution exposures. Jerrett et al. (2009) reported a
relative risk estimate for respiratory mortality in association with
long-term O3 exposure in the CPS-II cohort (hereafter referred to
as J2009), which was subsequently used to derive global
estimates of O3-attributable mortality ranging from 0.15 to 0.49
million deaths per year (Anenberg et al. 2010; Fang et al. 2013b;
GBD 2013 Risk Factors Collaborators 2015; GBD 2015 Risk
Factors Collaborators 2016; Lim et al. 2012; Silva et al. 2013,
2016a). In contrast, global estimates of mortality attributable to
ﬁne particulate matter (PM2:5) exposure (from cardiovascular, re-
spiratory, and lung cancer diseases) have been much higher, rang-
ing from 1.6 to 4.2 million per year (Anenberg et al. 2010; Fang
et al. 2013b; GBD 2013 Risk Factors Collaborators 2015; GBD
2015 Risk Factors Collaborators 2016; Lim et al. 2012; Silva
et al. 2013, 2016a).
Turner et al. (2016) recently reported updated CPS-II cohort
estimates of mortality risks associated with long-term O3 exposure
(hereafter referred to as T2016). The updated CPS-II estimates are
based on a larger study population with longer follow-up (669,046
participants and 237,201 deaths during 1982–2004) (Turner et al.
2016) than the previous estimates (448,850 participants and
118,777 deaths during 1982–2000) (Jerrett et al. 2009). In addition
to the diﬀerences noted above, the updated risk estimates reﬂect
other changes from the original study, which are described in detail
in Table S1. Importantly, there are diﬀerences in the O3 exposure
metric used in either study; in Jerrett et al. (2009), the summer aver-
age daily maximum 1-h O3 concentration was used (average of
April–June and July–September values), and in Turner et al. (2016),
the annual average daily maximum 8-h O3 concentration was used.
The purpose of the present analysis is to provide estimates of
global respiratory mortality attributable to long-term O3 exposure
based on the updated T2016 relative risk estimate and exposure
metric and compare them with estimates derived using the J2009
relative risk estimate and exposure metric. In addition, we report
estimates of ozone-attributable deaths due to COPD mortality
speciﬁcally.
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The evidence from epidemiological and toxicological studies
for associations, and causal linkages, between O3 exposure
(short- and long-term) and speciﬁc health outcomes has been
reviewed by the WHO and U.S. EPA (REVIHAAP 2013; U.S.
EPA 2013). For respiratory mortality, REVIHAAP (2013) identi-
ﬁed three cohort studies that linked long-term O3 exposure and
relevant outcomes, including respiratory mortality speciﬁcally
(Jerrett et al. 2009), COPD mortality (Zanobetti and Schwartz
2011), and cardiopulmonary mortality (Smith et al. 2009b). The
U.S. EPA (2013) concluded that there was “likely to be a causal
relationship between long-term exposure to O3 and respiratory
eﬀects” based on epidemiologic studies of respiratory mortality
(Jerrett et al. 2009; Zanobetti and Schwartz 2011), respiratory
morbidity (Jacquemin et al. 2012; Lin et al. 2008; Meng et al.
2010; Parker et al. 2009), and toxicological evidence of biologi-
cally plausible mechanisms for respiratory eﬀects of O3, includ-
ing “pulmonary function decrement and increases in respiratory
symptoms, lung inﬂammation, lung permeability, and airway
hyper-responsiveness” (U.S. EPA 2013). Evidence for causal
associations of O3 with speciﬁc causes of respiratory mortality is
more limited, with stronger evidence from studies of short-term
O3 and hospital admissions for both COPD and asthma compared
with pneumonia (Medina-Ramón et al. 2006; U.S. EPA 2013;
Zanobetti and Schwartz 2006), although a recent study reported
an association between short-term O3 exposure and hospital visits
for pneumonia, as well as COPD (Malig et al. 2016).
Methods
Long-Term O3 Exposure Estimation
Global gridded (2× 2:5, approximately 221× 278 km at the
equator) hourly O3 concentrations were simulated using the
GEOS-Chem Chemical Transport Model (Bey et al. 2001) driven
by GEOS-5 meteorological ﬁelds for 2010 from the Global
Modeling and Assimilation Oﬃce, with 47 vertical levels deﬁned
from the surface up to 0.01 hPa. Simulations used 2010 anthropo-
genic emissions from the Hemispheric Transport of Air Pollution
version-2 inventory (Janssens-Maenhout et al. 2015). The model
also considers additional emissions, described in further detail by
Lapina et al. (2014), which include biogenic VOCs, soil NOx,
lightning NOx, and monthly biomass burning emissions.
When estimating attributable deaths globally based on the
J2009 relative risk estimates, we used an O3 exposure metric that
was consistent with the premise of the exposure metric for which
the J2009 relative risk estimates were derived. Jerrett et al.
(2009) used the average daily maximum 1-h O3 concentration
between April and September as the O3 exposure metric in the
United States alone, where O3 concentrations are highest in
spring and summer months. In other regions, the seasonal pattern
of O3 variation is diﬀerent. To account for variability in the 6-mo
period with highest daily maximum 1-h O3 concentrations across
regions, we estimated, for each grid, annual maximum 6-mo av-
erage daily maximum 1-h (6mDM1h) O3 concentrations. The
6mDM1h metric calculated grid-by-grid accounts for diﬀerences
in seasonal O3 variation across the globe that aﬀects the timing of
the maximum 6-mo O3 concentration (Anenberg et al. 2010;
Silva et al. 2013, 2016a). When estimating attributable deaths
using the T2016 risk estimates, we used the annual average daily
maximum 8-h O3 concentration (ADM8h) for each grid, consis-
tent with the analysis from which the relative risk estimates were
derived. For each day, 24 eight-hour rolling mean O3 concentra-
tions were calculated as the average O3 concentration at the start
hour and the following 7 h. The maximum of the 24 eight-hour
O3 concentrations on each day were selected and averaged across
the year to derive the ADM8h concentration in each grid.
Exposure–Response Functions
Mortality attributable to long-term O3 exposure was estimated
for 181 countries in 2010 using Equations 1 and 2, consistent
with methodologies used to estimate global health impacts of O3
previously (Anenberg et al. 2010; Silva et al. 2013, 2016a):
DMort = y0ð1− exp
−bDXÞPop: [1]
HR= expbDY [2]
DMort is the change in mortality attributable to long-term O3
exposure, and was estimated separately for the population in each
grid cell covering a particular country. In this study, we estimated
DMort for each country in 2010 for respiratory mortality
[International Classiﬁcation of Diseases (ICD)-10 codes: J00–
J98], consistent with the causes of death investigated in Jerrett
et al. (2009) and Turner et al. (2016), and separately for chronic
obstructive pulmonary disease (COPD) mortality (ICD-10 codes:
J19–J46), a subset of respiratory mortality.
Pop. is the exposed population, which was the population in
each country ≥30 y of age, estimated from UN Population
Division population statistics disaggregated by age for each
country (https://esa.un.org/unpd/wpp/DataQuery/) because par-
ticipants in the ACS CPS-II cohort were required to be over 30 y
of age at enrollment. The population was distributed to the grids
covering each country using population count data for 2010 from
the Gridded Population of the World (GPW) version 3 dataset
(CIESIN-FAO-CIAT 2005). y0 is the baseline mortality rate for
each cause of death, derived as the ratio of the deaths of people
≥30 y of age from the cause and the number of people in each
country ≥30 y of age estimated by the UN Population Division
(https://esa.un.org/unpd/wpp/DataQuery/). For each country, the
total number of deaths for each disease category (respiratory and
COPD) for the population ≥30 y of age in 2010 were from the
GBD 2015 estimates derived by the Institute of Health Metrics
and Evaluation (GBD 2015 Mortality and Causes of Death
Collaborators 2016). Uncertainty in y0 was derived from the con-
ﬁdence intervals (CIs) reported by GBD 2015 Mortality and
Causes of Death Collaborators (2016) for the number of deaths
from each cause, as described below.
b is the eﬀect estimate [natural log of the hazard ratio (HR)]
for the association between long-term O3 concentrations and respi-
ratory or COPD mortality (Equation 2). In Jerrett et al. (2009), and
Turner et al. (2016), the HRs are reported as the increased hazard
of death for a 10-ppb increase in long-term O3 exposure, which is
DY in Equation 2. For J2009, in the main analysis we used the ln-
HR for a 10-ppb increase in O3 concentration (6mDM1h metric)
from the two-pollutant model adjusted for PM2:5 (HR=1:040;
95% CI: 1.013, 1.067), which has been applied in several previous
analyses (Anenberg et al. 2010; Fann et al. 2012; Silva et al. 2013,
2016a; West et al. 2013). For T2016, in the main analysis we used
the ln-HR for a 10-ppb increase in O3 concentration (ADM8h met-
ric) from a model adjusted for near-source PM2:5, regional PM2:5,
and NO2 (HR=1:12; 95% CI: 1.08, 1.16). This HR was used to
estimate updated long-term O3-attributable respiratory mortality
[using two low-concentration cutoﬀs (LCCs) to reﬂect uncertainty
in the concentration–response relationship below exposure levels
in Turner et al. (2016) (see below)]. T2016 relative risk estimates
for COPD mortality also were adjusted for PM2:5 (near-source and
regional) and NO2 [HR=1:14 (95% CI: 1.08, 1.21)].
Finally, DX is the long-term O3 exposure (estimated using
GEOS-Chem model output), expressed relative to a threshold ex-
posure (low-concentration cutoﬀ, or LCC), below which we
assume there is no eﬀect of O3 exposure on mortality. The spe-
ciﬁc LCCs used corresponded to the minimum O3 exposure or
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the ﬁfth percentile of O3 exposure in the respective ACS CPS-II
population on which each set of relative risk estimates (J2009 or
T2016) were based because the validity of each risk estimate is
uncertain for exposures below the actual levels experienced by
each population. For analyses based on J2009 relative risk esti-
mates and the 6mDM1h ozone exposure metric, LCCs for the
minimum and ﬁfth percentiles of exposure were set at 33:3 ppb
and 41:9 ppb, respectively; for analyses using T2016 relative risk
estimates and the ADM8h exposure metric, corresponding LCCs
were set at 26:7 ppb and 31:1 ppb. For each grid cell, DX was cal-
culated from the GEOS-Chem derived O3 concentration (O3_
GC) as
DX= f
0, if O3 GC≤LCC
O3 GC−LCC, if O3 GC>LCC
[3]
To derive central estimates of long-term O3-exposure attribut-
able respiratory, and COPD deaths for individual countries, we
applied Equation 1 for the population ≥30 y of age assigned to
each grid cell covering the country, using the central estimates of
b and the national baseline mortality rate (y0). To account for
uncertainty in the relative risk estimate (b) and baseline mortality
rates (y0), we sampled 1,000 estimates of b and y0 from normal
distributions based on the 95% CIs for each variable, applied
each resulting value to Equation 1 to derive 1,000 estimates of
long-term O3 attributable deaths, and used the resulting distribu-
tion to derive 95% CIs for attributable mortality in each grid cell.
Estimates for individual grids were summed to derive national,
regional, and global estimates, assuming dependence among the
gridded estimates.
Sensitivity analyses were performed to estimate long-term
O3-attributable mortality using T2016 relative risk estimates
derived using a single-pollutant model that did not adjust for
near-source PM2:5, regional PM2:5, or NO2 exposures [HR=1:14
(95% CI: 1.10, 1.18)]. In addition, we also performed analyses
using methods comparable with those used in previous studies to
estimate O3-attributable mortality. This allowed assessment of
the consistency of results obtained in those studies, with compa-
rable estimates using the O3 exposure, baseline mortality, and
population data used in this study. To make a direct comparison
with the Global Burden of Disease (GBD) analyses, we also fur-
ther estimated long-term O3-attributable deaths using comparable
methods. Speciﬁcally, GBD estimated long-term O3-attributable
deaths associated with chronic obstructive pulmonary disease
(COPD) only, using the maximum 3-mo average daily maximum
1-h O3 concentration, and the single-pollutant J2009 relative risk
estimate [1.029 (95% CI 1.010, 1.048)] that was derived for total
respiratory mortality (GBD 2013 Risk Factors Collaborators
2015; GBD 2015 Risk Factors Collaborators 2016; Lim et al.
2012).
Results
Globally, O3 exposure ranged between 13:6 ppb and 84:6 ppb
when quantiﬁed using the 6-mo daily maximum 1-h concentra-
tion (6mDMA1) relevant for the J2009 relative risk estimates,
and between 11:3 ppb and 72:6 ppb when quantiﬁed as the annual
daily maximum 8-h concentration (ADMA8) relevant for the
T2016 relative risk estimates (Table 1; see also Figure S1). Both
O3 exposure metrics were elevated across Asia (particularly India
and China) compared with other regions (Table 1).
Using the T2016 relative risk estimate (HR=1:12) and
ADM8h concentrations in each grid, we estimated that 1.23 mil-
lion (95% CI: 0.85, 1.62 million) respiratory deaths among the
global population ≥30 y of age were attributable to long-term O3
exposure in 2010 using the minimum exposure in the T2016
cohort (26:7 ppb) as the low-concentration cutoﬀ (LCC), and
1.04 million deaths (95% CI: 0.72, 1.37 million) using the ﬁfth
percentile LCC (31:1 ppb) (Table 2). Attributable deaths esti-
mated using the T2016 relative risk estimate and the ﬁfth percen-
tile LCC represent 20.3% (95% CI: 14.5, 26.9%) of all respiratory
deaths among those ≥30 y of age in 2010. In contrast, using the
J2009 relative risk (HR=1:04) and 6mDM1h concentrations, we
estimated 0.55 million (95% CI: 0.20, 0.90) deaths attributable to
long-term O3 in 2010 using the minimum exposure in the J2009
cohort as the LCC (33:3 ppb) and 0.40 million (95% CI: 0.14,
0.65) million attributable respiratory deaths using the ﬁfth per-
centile LCC (41:9 ppb).
The majority (79–81%) of our estimated long-term O3-
attributable respiratory deaths using the T2016 relative risk esti-
mates were in Asia (Table 2, Figure 1), predominantly in India
and China [37–39% of the global total for India depending on the
LCC, and 26% for both LCCs for China (Table 2)]. Applying the
T2016 relative risk estimates increased estimated long-term
Table 1. Range of O3 concentrations (ppb) in grids covering world regions and selected countries estimated from GEOS-chem model simulations.
Region Metric Minimum 5th percentile 25th percentile Median 75th percentile 95th percentile Maximum
Asia 6mDMA1 13.6 26.5 50.4 59.2 66.1 75.9 84.0
ADMA8 11.7 23.5 42.4 50.4 57.2 66.1 72.6
China 6mDMA1 46.2 51.7 59.9 64.4 70.2 78.5 84.0
ADMA8 40.9 43.7 50.6 54.5 59.6 67.7 72.6
India 6mDMA1 36.1 45.0 62.4 67.2 73.2 78.3 80.1
ADMA8 30.7 36.5 50.8 57.9 64.7 70.7 72.6
Europe 6mDMA1 36.9 38.7 40.2 42.6 48.9 57.8 66.0
ADMA8 30.3 33.5 35.0 37.8 41.1 48.9 54.3
Africa 6mDMA1 25.8 34.7 44.6 50.2 56.3 67.4 84.6
ADMA8 20.2 29.3 37.5 43.2 47.8 53.4 59.6
Latin America and the Caribbean 6mDMA1 15.8 22.3 29.9 38.7 49.5 59.0 78.5
ADMA8 11.3 15.6 24.5 32.3 39.7 50.1 62.6
North America 6mDMA1 39.3 39.8 41.4 43.8 51.7 64.8 77.3
ADMA8 34.1 35.6 37.0 39.4 44.0 54.4 58.8
United States 6mDMA1 39.6 40.3 43.3 51.8 60.1 68.8 77.3
ADMA8 34.1 36.3 38.6 44.5 50.9 55.6 58.8
Oceania 6mDMA1 13.6 18.5 25.8 33.0 35.9 38.0 40.3
ADMA8 11.7 15.0 20.1 29.2 32.7 34.5 37.6
Global 6mDMA1 13.6 26.8 39.8 44.8 54.8 68.9 84.6
ADMA8 11.3 22.5 34.4 39.0 46.3 58.2 72.6
Note: The range of the maximum 6-mo daily maximum 1-h O3 concentration (6mDMA1, relevant for J2009 relative risk estimates), and the annual average daily maximum 8-h con-
centrations (ADMA8, relevant for T2016 relative risk estimates) are shown. Ranges for China and India are shown because of the large health impacts estimated in these countries.
Ranges from the United States are also shown because this is where the Jerrett et al. (2009) and Turner et al. (2016) studies were conducted.
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O3- attributable respiratory deaths everywhere in the world
(Figure 2a), compared with the J2009 relative risk estimates (see
Figure S2), reﬂecting the common increase in the HR. However,
the increase in HR was oﬀset to a diﬀerent degree in diﬀerent
regions by the size of the decreases in the magnitude of the long-
term O3 exposure metric when quantiﬁed over the whole year
(T2016) rather than 6 mo (J2009), and expressed as a daily 8-h
maximum (T2016) rather than as a 1-h maximum (J2009). In those
regions with relatively large reductions in the magnitude of the
O3 metric (Figure 2c), the increase in estimated attributable
respiratory deaths was smaller than in those regions with a smaller
reduction in the O3 metric (Figure 2b). For example, there were
larger reductions in the O3 exposure metric, and smaller increases
in estimated attributable respiratory deaths, at northern midlati-
tudes (eastern United States, northeast China, and central and
northern Europe), compared with other regions (e.g., northern
India). The spatial diﬀerences in the magnitude of the all-year
compared with 6-mo metrics reﬂects diﬀerent seasonal variability
in O3 concentrations at northern midlatitudes, compared with other
regions (Monks et al. 2015).
Table 2. Global and regional estimates of respiratory deaths attributable to long-term O3 exposure for adults ≥30 y of age.
Region
Estimates based on J2009a Estimates based on T2016b
Low-concentration
cutoffc
Attributable respiratory
deaths J2009 (thousands)
Low-concentration
cutoffc
Attributable respiratory
deaths T2016 (thousands)
Proportion of total
respiratory deaths
(T2016 estimates, %)
Asia 33:3 ppb 430 (161, 699) 26:7 ppb 970 (686, 1,253) 28.0 (19.2, 35.8)
41:9 ppb 328 (120, 536) 31:1 ppb 844 (593, 1,095) 24.3 (17.1, 31.9)
China 33:3 ppb 154 (59.9, 248) 26:7 ppb 316 (230, 403) 28.0 (20.5, 35.9)
41:9 ppb 120 (45.6, 195) 31:1 ppb 274 (198, 351) 24.2 (17.2, 31.3)
India 33:3 ppb 193 (74.8, 311) 26:7 ppb 450 (329, 572) 32.2 (23.5, 41.3)
41:9 ppb 151 (57.2, 246) 31:1 ppb 402 (291, 513) 28.7 (20.0, 37.3)
Europe 33:3 ppb 39.2 (13.9, 64.5) 26:7 ppb 78.9 (54.2, 104) 15.0 (10.4, 19.7)
41:9 ppb 22.5 (7.7, 37.2) 31:1 ppb 55.9 (38.1, 73.8) 10.6 (6.9, 14.1)
Africa 33:3 ppb 33.6 (6.6, 60.6) 26:7 ppb 80.6 (37.1, 124) 15.9 (7.5, 24.6)
41:9 ppb 18.8 (3.6, 34.1) 31:1 ppb 59.6 (27.5, 91.6) 11.7 (5.8, 19.1)
Latin America and the Caribbean 33:3 ppb 14.5 (5.1, 23.9) 26:7 ppb 39.9 (27.4, 52.4) 12.0 (8.2, 15.4)
41:9 ppb 6.5 (2.3, 10.8) 31:1 ppb 27.2 (18.6, 35.7) 8.2 (5.4, 10.8)
North America 33:3 ppb 30.1 (11.5, 48.7) 26:7 ppb 63.8 (46.3, 81.3) 23.9 (17.3, 30.6)
41:9 ppb 22.0 (8.2, 35.8) 31:1 ppb 53.5 (38.4, 68.5) 20.0 (14.5, 25.8)
Oceania 33:3 ppb 0.2 (0.06, 0.28) 26:7 ppb 1.0 (0.7, 1.3) 3.7 (2.4, 5.3)
41:9 ppb 0d 31:1 ppb 0.4 (0.3, 0.6) 1.5 (1.0, 2.1)
Global 33:3 ppb 547 (198, 897) 26:7 ppb 1,234 (851, 1,616) 24.0 (16.9, 31.7)
41:9 ppb 398 (142, 654) 31:1 ppb 1,040 (716, 1,365) 20.3 (14.5, 26.9)
Note: Estimates were calculated using relative risk estimates for long-term O3 exposure and respiratory mortality derived in Jerrett et al. (2009) and Turner et al. (2016) and are also
reported as a proportion of all respiratory deaths for the population aged ≥30 y in each region. Values in parentheses are 95% confidence intervals.
aJ2009 estimates use HR=1:040 (95% CI: 1.013, 1.067) as the relative risk estimate and the maximum 6-mo daily 1-h maximum O3 concentration as the exposure metric (Jerrett et al. 2009).
bT2016 estimates use HR=1:12 (95% CI: 1.08, 1.16) as the relative risk estimate and the annual daily 8-h maximum ozone concentration as the exposure metric (Turner et al. 2016).
cLower value is the minimum ozone concentration, and the upper value is the 5th percentile of the ozone concentration for the population and ozone metric used to derive the J2009
and T2016 relative risk estimates.
dEstimated maximum 6-mo O3 concentrations did not exceed the 5th percentile low-concentration cutoff in Oceania, and therefore no long-term O3-attributable respiratory deaths
were estimated.
Figure 1. Estimated long-term O3-exposure attributable respiratory deaths in 2010 for adults ≥30 y of age. Units are attributable deaths per 100,000 people,
and estimates were derived using the T2016 relative risk estimate [HR=1:12 (95% CI: 1.08, 1.16), adjusted for near-source and regional PM2:5, and NO2 expo-
sure] and annual average daily maximum 8-h O3 concentration as the O3 exposure metric, with a low-concentration cutoﬀ set at the minimum exposure in the
Turner et al. (2016) cohort (26:7 ppb) (Map Data: © EuroGeographics for the administrative boundaries).
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Figure 2. Spatial distribution of changes in estimated long-term O3-attributable respiratory deaths when using the J2009 relative risk estimates [HR=1:04
(95% CI: 1.013, 1.067), adjusted for total PM2:5 exposure] and 6-mo daily maximum 1-h concentration as the O3 exposure metric (33:3-ppb low-concentration
cutoﬀ), and T2016 relative risk estimates [HR=1:12 (95% CI: 1.08, 1.16), adjusted for near-source and regional PM2:5, and NO2 exposure] and annual average
daily maximum 8-h concentration as the O3 exposure metric (26:7-ppb low-concentration cutoﬀ). (a) shows the absolute diﬀerence in attributable respiratory
deaths per 100,000 people estimated using the J2009 and T2016 relative risk estimates. (b) shows the percent of T2016-based attributable respiratory death esti-
mates accounted for by J2009-based attributable respiratory deaths estimates (colder colors indicate a smaller increase in estimated O3-attributable respiratory
deaths when calculated using the T2016 relative risk estimate, warmer colors indicate a larger increase). (c) shows the percent decrease in the magnitude of the
long-term O3 exposure metric when using the annual average daily maximum 8-h metric (relevant for T2016 relative risk estimates), compared with the maxi-
mum 6-mo average daily maximum 1-h metric (relevant for J2009 relative risk estimates). Gray areas in each panel indicate those grids where the 6-mo or an-
nual O3 exposure metric was below the LCC, and therefore no O3-attributable respiratory deaths were estimated (Map Data: © EuroGeographics for the
administrative boundaries).
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In addition, the T2016 relative risk estimates were also
applied with diﬀerent LCCs compared with the J2009 relative
risk estimates. The use of an annual metric to characterize popu-
lation O3 exposure compared with a 6-mo metric shifts the distri-
bution of the O3 exposure metric in diﬀerent regions, including in
relation to the relevant LCCs. For example, the median ADM8h
concentration across all grids globally was 46% greater than the
minimum exposure LCC (26:7 ppb), compared with 35% greater
for the median 6mDM1h concentration (33:3 ppb LCC), that is, a
33% larger exceedance of the minimum exposure LCC for the
median ADM8h metric (Table 1). However, in Asia the exceed-
ance of the LCC for the median ADM8h concentration was only
14% greater than for the median 6mDM1h concentrations, com-
pared with 49% and 51% in Europe and North America, respec-
tively (Table 1). Hence in diﬀerent regions the change in the
extent to which the O3 exposure metrics exceed the LCC diﬀers
and contributes to regional diﬀerences in the increase in esti-
mated O3-attributable respiratory mortality when applying the
T2016 relative risk estimates.
We performed a sensitivity analysis of estimated O3-
attributable respiratory deaths using a T2016 relative risk esti-
mate derived from a single-pollutant model, instead of the multi-
pollutant adjusted estimate used for the primary analyses.
Estimated numbers of ozone-attributed respiratory deaths based
on the single-pollutant model relative risk estimates were approx-
imately 13% higher than the estimates derived using the multi-
pollutant model relative risk estimates (see Table S2).
The O3-attributable respiratory mortality estimates using the
J2009 relative risk estimate, as described above (HR=1:040;
95% CI: 1.013, 1.067; 33:3 ppb and 41:9 ppb LCCs), were com-
parable with previous estimates in Anenberg et al. (2010), Fang
et al. (2013b), Silva et al. (2013), and Silva et al. (2016a) (see
Table S4). In comparison with previous estimates of long-term
O3 attributable mortality by the Global Burden of Disease (GBD)
project, our estimates using GBD-comparable inputs to Equation
1 (i.e., estimating O3-attributable COPD mortality using the
J2009 single-pollutant relative risk estimate for respiratory mor-
tality and maximum 3-mo daily maximum 1-h O3 exposure met-
ric) had overlapping conﬁdence intervals with GBD 2010, GBD
2013, and GBD 2015 long-term O3-attributable deaths (GBD
2013 Risk Factors Collaborators 2015; GBD 2015 Risk Factors
Collaborators 2016; Lim et al. 2012), but our central estimates
were higher (see Table S3). Diﬀerences in the magnitude of O3
exposure estimates, derived from the Tracer Model v5-FAst
Scenario Screening Tool model in GBD (Brauer et al. 2016) and
GEOS-Chem here, may contribute to this discrepancy. For exam-
ple, in India and China, population-weighted 3-mo maximum
daily 1-h concentrations were 5% (1:1-ppb), and 22% (14-ppb)
higher for GEOS-Chem, respectively. Further work is required to
evaluate the performance of both models in these regions, which
have the largest estimated health burden, although currently there
is relatively low number and spatial density of monitoring sites in
these regions to achieve this (Cooper et al. 2014).
Application of the T2016 relationships for COPD mortality
speciﬁcally resulted in an estimated 0.86 million (95% CI: 0.53,
1.18 million) O3-attributable COPD deaths across the global pop-
ulation ≥30 y of age in 2010 using the minimum exposure in the
T2016 cohort (26:7 ppb) as the LCC, and 0.74 million deaths
(95% CI: 0.45, 1.02 million) using the ﬁfth percentile LCC
(31:1 ppb) (see Table S4, Figure S3). This indicates that esti-
mated O3-attributable COPD deaths were approximately 70–71%
of total estimated O3-attributable respiratory deaths. Hence, even
when only focusing on COPD, long-term O3 health impacts may
be more signiﬁcant than previously estimated [e.g., global long-
term O3 COPD deaths estimated by GBD 2015 were 6% of
PM2:5-associated attributable deaths, whereas our estimates using
T2016 relationships are 17–20% of this PM2:5-attributable death
estimate (GBD 2015 Risk Factors Collaborators 2016)].
Discussion
Results of this study estimating the global burden and spatial dis-
tribution of long-term O3 exposure on mortality applying the re-
vised T2016 relative risk estimates estimated 1.04–1.23 million
respiratory deaths among the global population ≥30 y of age
were attributable to O3 exposure in 2010. The more than dou-
bling of estimated long-term O3-attributable respiratory deaths
obtained using the T2016 compared with J2009 relative risk
estimates (0.40–0.55 million attributable respiratory deaths)
increases the estimated contribution of O3 to the global outdoor
air pollution health burden. The respiratory mortality results for
O3 are 25–29% of the 4.2 million deaths estimated to be attribut-
able to PM2:5 exposure by the Global Burden of Disease (GBD)
(GBD 2015 Risk Factors Collaborators 2016).
Previous long-term O3 attributable mortality estimates have
used O3 exposure over a 6-mo period for consistency with the O3
exposure estimates in Jerrett et al. (2009) (Anenberg et al. 2010;
Fang et al. 2013b; Silva et al. 2013, 2016a) (the GBD studies
have applied the J2009 relative risk estimates using a 3-mo met-
ric (Brauer et al. 2016; Cohen et al. 2017)). The 3- and 6-mo met-
rics previously applied to estimate long-term O3 health burdens
do not account for O3 exposure that occurs during the rest of the
year, which varies diﬀerently between regions. For example, at
northern midlatitudes, including North America, Europe, and
northeast China, there is substantial annual O3 variation, with a
peak during spring months. In contrast, closer to the equator,
there is less annual variation in O3 concentrations (Monks et al.
2015). Hence annual averaged O3 concentrations are substan-
tially lower than 3- or 6-mo concentrations at northern midlati-
tudes compared with closer to the equator (Figure 2, Table 1).
This work shows that when O3 exposure across the whole year
is taken into account the spatial distribution of estimated
O3-attributable respiratory mortality shifts in from the northern
midlatitudes towards the equator, compared with previous analy-
ses that quantiﬁed O3 exposure only during part of the year.
Consequently, the relative increase in estimated long-term O3 at-
tributable respiratory mortality using the T2016 compared with
J2009 method was 134–165% for India, compared with 105–
128% for China, 112–143% for North America and 101–148%
for Europe.
The T2016 relative risk estimates used in the present analysis
were derived using improved O3 exposure estimates that com-
bined monitored data with photochemical model output (Turner
et al. 2016). In addition, we used T2016 relative risk estimates
from multi-pollutant models adjusted for NO2 and for “near-
source” and “regional” PM2:5 that have diﬀerent correlation
structures with O3. In contrast, previous global estimates of long-
term O3-attributable deaths used J2009 relative risk estimates
from a single-pollutant model [e.g., GBD 2015 Risk Factors
Collaborators 2016), or a multi-pollutant model adjusted for total
PM2:5 concentrations only (e.g., Anenberg et al. (2010)], but
within which there was a moderate correlation between O3 and
PM2:5 exposure estimates. Hence the long-term O3-attributable
death estimates presented in this work should be more indepen-
dent of health burdens associated with exposure to PM2:5 and
NO2.
Additionally, the consistency of the association between ex-
posure to ﬁne particulate matter (PM2:5) and mortality in multiple
ACS CPS-II cohort analyses to diﬀerent estimates of O3 exposure
suggests that the stronger relationship between long-term O3 ex-
posure and attributable mortality in Turner et al. (2016) may
Environmental Health Perspectives 087021-6
represent an additional contribution to the outdoor air pollution
health burden, as opposed to a reattribution of PM2:5-associated
premature deaths to long-term O3 exposure. For example, the rel-
ative risk estimates derived in Turner et al. (2016) between long-
term PM2:5 exposure and all-cause mortality [HR for a 10-lgm
−3
increase in PM2:5 concentration, single-pollutant model: 1.07
(95% CI: 1.06, 1.09) multipollutant model using alternative esti-
mate of PM2:5 exposure: 1.06 (95% CI: 1.04, 1.08)] was similar
to that derived in the Krewski et al. (2009) [HR: 1.06 (95% CI:
1.04, 1.08)], and Pope et al. (2002) [HR: 1.06 (95% CI: 1.02,
1.11)] analyses of the ACS CPS-II cohort.
Turner et al. (2016) also calculated a signiﬁcant association
with cardiovascular mortality in addition to the signiﬁcant associ-
ation calculated between long-term O3 exposure and respiratory
mortality. This is in contrast to Jerrett et al. (2009) where a signif-
icant inverse relationship between long-term O3 exposure and
cardiovascular mortality was calculated. The evidence for associ-
ations, and causal linkages, between long-term O3 exposure and
cardiovascular mortality has been reviewed by the WHO and the
U.S. EPA (REVIHAAP 2013; U.S. EPA 2013). REVIHAAP
(2013) identiﬁed three cohort studies that estimated a signiﬁcant
relationship between long-term O3 exposure and mortality, which
includes, or is a subset of, cardiovascular mortality. One study
calculated an association with ischemic heart disease (IHD)
(Lipsett et al. 2011), one study with cardiopulmonary disease
(Smith et al. 2009a), and one with congestive heart failure
(Zanobetti and Schwartz 2011). Based on the evidence from a
limited number of epidemiological and toxicological studies, the
U.S. EPA concluded that the available evidence is only “sugges-
tive of a causal relationship between long-term exposure to O3
and cardiovascular eﬀects” (U.S. EPA 2013), whereas Prueitt
et al. (2014) concluded that the evidence from epidemiological,
and human and animal toxicological studies is “below equi-
poise,” that is, not suﬃcient to conclude that a causal relationship
is as least as likely as not. Hence because the evidence for a
causal association between long-term O3 exposure and cardiovas-
cular mortality is limited compared with respiratory mortality, we
did not estimate the global impact of long-term O3 exposure on
cardiovascular mortality. However, if additional evidence shows
that the T2016 relative risk estimate between long-term O3 expo-
sure and cardiovascular mortality is valid (Schwartz 2016), then
the inclusion of cardiovascular mortality would increase the esti-
mated O3 health burden further.
Uncertainties
Limitations of this study include estimation of long-term O3 ex-
posure using a single global chemistry transport model at global
grid resolution (2 × 2:5, 221× 278 km at the equator), that does
not account for local-scale variability in O3 concentrations
(Monks et al. 2015). However, previous studies indicate only a
modest eﬀect of grid spatial resolution on O3 attributable mortal-
ity estimates because the spatial gradients in O3 concentrations
are typically smoother than those of population distribution.
Punger and West (2013) calculated a less than 6% increase in O3 at-
tributable mortality estimates in the United States, when derived
using modeled O3 concentrations at a 100–400 km grid scale com-
pared with the ﬁnest (12 km) resolution. Furthermore, using GEOS-
Chem, we obtained similar long-term O3-attributable death esti-
mates to previous studies using consistent methods (including
the GBD, see Table S3), based on J2009 relationships, including
those using chemical transport models with ﬁner grid resolution
(see Table S3).
Compared with 1,420 monitoring sites globally (85% of
which were in the United States), a mean bias of + 10:8 ppb was
calculated for GEOS-Chem, which was consistent with biases
estimated in other global models as part of multi-model compari-
son projects (Yan et al. 2016). This bias was identiﬁed by Yan
et al. (2016) to be partly due to small scale nonlinear chemical
processes that are not captured at the grid resolution of the
GEOS-Chem model used here. Similarly, in China, where some
of the highest health burdens were estimated, a positive bias was
calculated in comparison with available measurements, for exam-
ple, Zhu and Liao (2016): mean bias of + 11:6% based on moni-
toring data from 10 Chinese sites (i.e., GEOS-Chem modeled O3
concentrations were on average 11.6% higher than the measured
concentration), and Lou et al. (2014): mean bias of + 9% com-
pared with data from 12 Chinese sites. Hence, accounting for
these smaller-scale nonlinear processes in the GEOS-Chem
global model, and in global models in general, may therefore
yield somewhat lower estimates of O3 exposure than estimated in
this study. Ongoing eﬀorts to harmonize and synthesize available
measurement data worldwide will be particularly useful to extend
model-measurement comparison with other regions (including
those with the highest estimated O3 health burdens) (Cooper
et al. 2014; http://www.igacproject.org/TOAR), as is further
work to increase global monitoring data coverage. Further evalu-
ation of modeled O3 exposure estimates through inter-model and
measurement comparisons is also warranted.
Consistent with previous analyses of the GBD, we used rela-
tive risk estimates derived from a U.S. cohort to estimate mortal-
ity attributable to long-term O3 exposure throughout the world.
This assumes that the relative risk estimates for the ACS CPS-II
population are transferable to all populations globally, for which
the prevalence of other risk factors for respiratory mortality, such
as socioeconomic status, access to health care, nutrition, race/eth-
nicity, education, and other competing risks may be diﬀerent
from the predominantly white, high-school educated CPS-II
cohort population. Although Turner et al. (2016) adjusted for
many of these confounders in analyzing the ACS CPS-II cohort,
a limitation of this study is the application of the T2016 relative
risk estimates to populations where the distribution of these risk
factors is likely to be substantially diﬀerent from the distribution
across the ACS CPS-II population. The two European cohort
studies that have assessed long-term O3 exposure and mortality
estimated null or negative associations between O3 exposure and
respiratory mortality (Bentayeb et al. 2015; Carey et al. 2013),
and no such cohort studies have been conducted outside North
America and Europe (Atkinson et al. 2016). In some regions, our
modeled annual daily maximum 8-h O3 concentrations (Table 1;
see also Figure S1) were higher than for the Turner et al. (2016)
cohort (maximum estimated exposure of Turner et al. (2016)
cohort: 59:3 ppb). The T2016 HRs for ozone and mortality
reported by Turner et al. (2016) were based on estimated O3 expo-
sures in the United States during 2002–2004, at the end of a 24-y
period during which O3 precursor emissions decreased substan-
tially in the United States (Simon et al. 2015). Their application to
regions with increasing O3 precursor emissions since the 1980s is
therefore uncertain (Monks et al. 2015). Further investigation is
required to determine the relationship between changing long-term
O3 exposure and mortality in regions with increasing emissions.
Finally, potential interactions between exposure to O3 and other
pollutants (e.g., PM2:5) and impacts on mortality were not consid-
ered by Turner et al. (2016). Hence long-term O3-attributed mortal-
ity estimates reported here assume independence of eﬀects of each
pollutant. As additional epidemiological data becomes available
on potential interactions between exposure to O3 and PM2:5 (and
other pollutants), or on the transferability of eﬀect estimates
between regions, long-term O3-attributable mortality estimates
should be updated to account for the improved understanding of
these aspects of O3 impacts on mortality.
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Conclusions
To evaluate the overall outdoor air pollution health burden, mor-
tality attributable to O3 and PM2:5 exposure has been estimated at
global (Anenberg et al. 2010; Fang et al. 2013b; GBD 2013 Risk
Factors Collaborators 2015; Lelieveld et al. 2015; Likhvar et al.
2015; Silva et al. 2013), regional (Crippa et al. 2016), and
national scales (Caiazzo et al. 2013; Fann et al. 2012; Kim et al.
2015), and many studies have used relative risk estimates derived
from the ACS CPS-II cohort (Jerrett et al. 2009) to estimate mor-
tality attributable to ozone air pollution in adults ≥30 y of age.
Our ﬁndings suggest that the potential impact of long-term O3 ex-
posure on respiratory mortality is substantially higher when respi-
ratory deaths attributable to long-term O3 exposure are estimated
using updated relative risks, exposure metrics, and low-
concentration thresholds from the ACS CPS-II cohort (Turner
et al. 2016). We estimated 1.04–1.23 million long-term O3 attrib-
utable respiratory deaths using the updated assumptions, a 126–
161% increase from estimates derived using assumptions based
on an earlier analysis of the ACS CPS-II cohort (Jerrett et al.
2009). This study indicates that reducing O3 exposure, for exam-
ple, through reduction of precursor emissions (i.e., methane,
NOx, VOCs, and CO), could have substantially greater beneﬁts
than previously quantiﬁed in reducing the overall global burden
of disease attributable to outdoor air pollution. Furthermore,
human health co-beneﬁts from climate mitigation policies
(Anenberg et al. 2012; Shindell et al. 2012, 2016; West et al.
2013), and health burdens from climate-driven changes in O3
concentrations (Fang et al. 2013a; Silva et al. 2016b; Zhu and
Liao 2016) may also be greater than previously estimated.
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